Cellular Therapy
News
Guideline updated on hematopoietic colony-stimulating factors
News
CD8 cell dose predicts outcomes in allogeneic stem cell transplantation with reduced-intensity conditioning
Key clinical point: High CD8 cell dose in peripheral blood stem cell grafts was associated with reduced risk of relapse and increased survival in...
News
Chemotherapy and stem-cell transplantation combination appears safe
Key clinical point: In Jehovah’s Witness patients with relapsed lymphoma or multiple myeloma, high-dose chemotherapy (HDC) followed by autologous...
News
Chronic lymphocytic leukemia prognosis relatively good after transplantation failure
Key clinical point: The prognosis for patients with chronic lymphocytic* leukemia who have undergone failed stem cell transplantation (SCT) is...
Conference Coverage
CAR-T cell therapy rolls on in pediatric ALL
Key clinical point: CAR-T cell therapy continues to provide durable responses in early studies of children with refractory ALL. Major finding:...
Conference Coverage
VALOR: Baby step forward or misstep in AML?
Key clinical point: Vosaroxin plus cytarabine failed to significantly improve overall survival in relapsed or refractory AML, but may offer older...
Conference Coverage
Brentuximab changes landscape for post-transplant Hodgkin’s lymphoma patients
Key clinical point: Brentuximab vedotin given immediately post-transplant significantly improves progression-free survival in patients with...
News
Vitiligo, alopecia more likely in GVHD when donor is female and recipient is male
Key clinical point: Female-to-male stem cell donation ups the risk for vitiligo in GVHD. Major finding: 14 of the 15 patients who developed...
News
Monosomal karyotype, high prognostic risk score predicted transplantation failure
Major finding: Patients with a monosomal karyotype had a 49% relapse rate and a 10% 5-year overall survival rate, and those considered high or...